Radiation & Systemic Therapy
Prophylactic radiation therapy to the male breasts is administered to avoid painful enlargement of the breasts when the patient starts on hormones. Radiation to the male breast should not be coded as cancer-directed radiation therapy.
Systemic therapy is typically not recommended for early prostate cancer but is effective for regionalized or metastatic disease. Occasionally, anti-androgens (such as lupron, casodex, or flutamide) are given for early stage prostate cancer.